McHugh R Kathryn, Weiss Roger D, Cornelius Marise, Martel Marc O, Jamison Robert N, Edwards Robert R
Division of Alcohol and Drug Abuse, McLean Hospital, Belmont, Massachusetts; Department of Psychiatry, Harvard Medical School, Boston, Massachusetts.
Division of Alcohol and Drug Abuse, McLean Hospital, Belmont, Massachusetts; Department of Psychiatry, Harvard Medical School, Boston, Massachusetts.
J Pain. 2016 Jul;17(7):806-14. doi: 10.1016/j.jpain.2016.03.004. Epub 2016 Apr 4.
UNLABELLED: The risk for misuse of opioid medications is a significant challenge in the management of chronic pain. The identification of those who may be at greater risk for misusing opioids is needed to facilitate closer monitoring of high-risk subgroups, and may help to identify therapeutic targets for mitigating this risk. The aim of this study was to examine whether distress intolerance-the perceived or actual inability to manage negative emotional and somatic states-was associated with opioid misuse in those with chronic pain. A sample of 51 participants prescribed opioid analgesics for chronic back or neck pain were recruited for a 1-time laboratory study. Participants completed measures of distress intolerance and opioid misuse, and a quantitative sensory testing battery. Results suggested that distress intolerance was associated with opioid misuse, even controlling for pain severity and negative affect. Distress intolerance was not associated with pain severity, threshold, or tolerance, but was associated with self-reported anxiety and stress after noxious stimuli. This study found robust differences in distress intolerance between adults with chronic pain with and without opioid medication misuse. Distress intolerance may be a relevant marker of risk for opioid misuse among those with chronic pain. PERSPECTIVE: This study demonstrated that distress intolerance was associated with opioid misuse in adults with chronic pain who were prescribed opioids. Distress intolerance can be modified with treatment, and thus may be relevant not only for identification of risk for opioid misuse, but also for mitigation of this risk.
未标注:阿片类药物滥用风险是慢性疼痛管理中的一项重大挑战。需要识别那些可能更易滥用阿片类药物的人群,以便对高风险亚组进行更密切的监测,并可能有助于确定减轻这种风险的治疗靶点。本研究的目的是检验痛苦不耐受——即感知到的或实际存在的无法应对负面情绪和躯体状态的能力——是否与慢性疼痛患者的阿片类药物滥用有关。招募了51名因慢性背部或颈部疼痛而开具阿片类镇痛药的参与者进行一项一次性实验室研究。参与者完成了痛苦不耐受和阿片类药物滥用的测量,以及一组定量感觉测试。结果表明,即使在控制了疼痛严重程度和负面影响之后,痛苦不耐受仍与阿片类药物滥用有关。痛苦不耐受与疼痛严重程度、阈值或耐受性无关,但与有害刺激后的自我报告焦虑和压力有关。本研究发现,在有和没有阿片类药物滥用的慢性疼痛成年人中,痛苦不耐受存在显著差异。痛苦不耐受可能是慢性疼痛患者阿片类药物滥用风险的一个相关标志物。 观点:本研究表明,痛苦不耐受与开具阿片类药物的慢性疼痛成年人的阿片类药物滥用有关。痛苦不耐受可以通过治疗得到改善,因此不仅可能与阿片类药物滥用风险的识别有关,而且与减轻这种风险有关。
Drug Alcohol Depend. 2013-4-22
Curr Opin Psychol. 2025-4
Psychol Addict Behav. 2024-12
Psychol Addict Behav. 2024-6
Anaesthesia. 2023-9
Curr Opin Support Palliat Care. 2015-6
Assessment. 2015-12
Behav Ther. 2013-11-13
Cognit Ther Res. 2011-6
Drug Alcohol Depend. 2013-4-22
Behav Ther. 2011-12-20